Current multimodal diagnostic tools for diabetic macular edema to select a management strategy

Q4 Medicine

Russian Journal of Clinical Ophthalmology Pub Date : 2021-01-01 DOI:10.32364/2311-7729-2021-21-4-210-214

M. V. Pshenichnov

{"title":"Current multimodal diagnostic tools for diabetic macular edema to select a management strategy","authors":"M. V. Pshenichnov","doi":"10.32364/2311-7729-2021-21-4-210-214","DOIUrl":null,"url":null,"abstract":"Diabetes is a severe chronic disease that significantly affects the quality of life of individuals, their families, and society worldwide. Diabetic retinopathy, particularly diabetic macular edema (DME), is the leading cause of blindness and low vision among adults of working age in developed countries and Russia. A recent multimodal approach to diagnose DME resulted in new classifications of this disorder and slightly modified earlier views. The analysis of DME biomarkers allows for selecting management strategies for each patient, prescribing adequate medical treatment, and predicting potential treatment response. This paper aimed to analyze published data and up-to-date diagnostic approaches to DME. These tools provide a correct therapeutic strategy based on the DME pattern. Keywords: diabetic macular edema, optical coherence tomography, anti-VEGF treatment. For citation: Pshenichnov M.V. Current multimodal diagnostic tools for diabetic macular edema to select a management strategy. Russian Journal of Clinical Ophthalmology. 2021;21(4):210–214 (in Russ.). DOI: 10.32364/2311-7729-2021-21-4-210-214.","PeriodicalId":36455,"journal":{"name":"Russian Journal of Clinical Ophthalmology","volume":"20 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Clinical Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32364/2311-7729-2021-21-4-210-214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Diabetes is a severe chronic disease that significantly affects the quality of life of individuals, their families, and society worldwide. Diabetic retinopathy, particularly diabetic macular edema (DME), is the leading cause of blindness and low vision among adults of working age in developed countries and Russia. A recent multimodal approach to diagnose DME resulted in new classifications of this disorder and slightly modified earlier views. The analysis of DME biomarkers allows for selecting management strategies for each patient, prescribing adequate medical treatment, and predicting potential treatment response. This paper aimed to analyze published data and up-to-date diagnostic approaches to DME. These tools provide a correct therapeutic strategy based on the DME pattern. Keywords: diabetic macular edema, optical coherence tomography, anti-VEGF treatment. For citation: Pshenichnov M.V. Current multimodal diagnostic tools for diabetic macular edema to select a management strategy. Russian Journal of Clinical Ophthalmology. 2021;21(4):210–214 (in Russ.). DOI: 10.32364/2311-7729-2021-21-4-210-214.

查看原文本刊更多论文

当前多模式诊断工具对糖尿病性黄斑水肿的治疗策略选择

糖尿病是一种严重的慢性疾病，严重影响全世界个人、家庭和社会的生活质量。糖尿病视网膜病变，特别是糖尿病性黄斑水肿(DME)，是发达国家和俄罗斯工作年龄成年人失明和视力低下的主要原因。最近诊断二甲醚的多模式方法导致了这种疾病的新分类，并稍微修改了先前的观点。DME生物标志物的分析允许为每个患者选择管理策略，开出适当的医疗处方，并预测潜在的治疗反应。本文旨在分析已发表的数据和最新的诊断方法DME。这些工具提供了基于DME模式的正确治疗策略。关键词:糖尿病性黄斑水肿，光学相干断层扫描，抗vegf治疗。引用本文:Pshenichnov M.V.当前糖尿病黄斑水肿的多模式诊断工具选择管理策略。俄罗斯临床眼科杂志。2021;21(4):210-214(俄文)。DOI: 10.32364 / 2311-7729-2021-21-4-210-214。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊